GW&K Investment Management LLC reduced its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 425,684 shares of the business services provider's stock after selling 6,633 shares during the quarter. GW&K Investment Management LLC owned about 0.84% of Exponent worth $34,505,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in Exponent in the 4th quarter valued at $52,381,000. Resona Asset Management Co. Ltd. purchased a new stake in Exponent in the 4th quarter valued at $38,538,000. BLI Banque de Luxembourg Investments purchased a new stake in Exponent in the 4th quarter valued at $12,564,000. Barclays PLC grew its holdings in Exponent by 88.5% in the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock valued at $16,209,000 after buying an additional 85,395 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Exponent by 1,061.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 85,790 shares of the business services provider's stock valued at $7,644,000 after buying an additional 78,401 shares in the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Exponent
In related news, VP Joseph Rakow sold 1,573 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total transaction of $122,253.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Bradley A. James sold 2,694 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total value of $214,226.88. The disclosure for this sale can be found here. Insiders sold 6,267 shares of company stock worth $489,120 in the last three months. 1.60% of the stock is owned by company insiders.
Exponent Trading Up 0.7%
NASDAQ:EXPO traded up $0.49 during trading hours on Friday, hitting $72.62. The company had a trading volume of 55,632 shares, compared to its average volume of 304,965. The company has a market cap of $3.69 billion, a P/E ratio of 35.33 and a beta of 0.90. Exponent, Inc. has a 1 year low of $71.29 and a 1 year high of $115.75. The company has a 50-day moving average of $75.72 and a 200 day moving average of $81.12.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The company's quarterly revenue was up .2% on a year-over-year basis. During the same period last year, the company earned $0.59 EPS. On average, analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date was Friday, June 6th. Exponent's payout ratio is 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.